Stock screenerAll disclosures →
EDGAR →
MGX
Conviction 20HealthcareScan · Thu, Jun 25, 2026MGX$1.19-0.83%
ResistanceSupportVol 14Insider sell3
Vol MA14 210.41K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.19
Change-0.83%
Gap+0.83%
Rel volume7.36×
Avg volume199.42K
Avg $ vol247.1K
SMA 201.25
SMA 501.34
SMA 2001.73
Price vs 50-11.05%
Price vs 200-31.14%
MA stackbearish
50/200 cross—
Supertrenddown · 1.34
RSI (14)40
MACD hist0.00
MACD crossbull · 1d
Stoch %K / %D29 / 34
ADX (14)16
+DI / −DI17 / 19
RSI divergence—
MACD divergence—
ATR %+5.56%
ADR %5.00%
52w high3.35
52w low1.14
From 52w high-64.48%
Above 52w low+4.39%
New 52w highNo
SqueezeOff
Bollinger width22.44%
%B0.28
Donchian pos22.22%
Donchian high1.40
Donchian low1.13
AVWAP (52w high)1.93
vs AVWAP high-38.25%
AVWAP (52w low)1.19
vs AVWAP low-0.10%
OBV trendDown
Chaikin MF (20)-0.36
Today vs 20d7.36×
Avg vol (14d)210.41K
Avg vol (20d)199.42K
Avg $ vol (20d)247.1K
Market cap44.8M
RS 3m (vs SPY)-24.67%
RS 6m (vs SPY)-39.55%
RS line new highNo
Trend template0/8
Technical rank15.8
1 week+0.85%
1 month-12.50%
3 months-14.39%
6 months-32.00%
1 year-22.73%
YTD-28.74%
P/E-0.51
P/B0.33
P/S1.78
P/FCF-0.50
EPS-2.36
Div yield—
ROE-63.77%
ROA-44.61%
Debt/Eq—
Current6.43
EV/EBITDA—
Gross margin—
Net margin-348.54%
Rev growth-51.79%
EPS growth-12.57%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value19.49M
Revenue1.25M
Net income-23.06M
Gross profit—
Free cash flow-89.47M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out37.65M
Employees118
ListedFri, Feb 9, 2024
Free float22.51M
Float %60.0%
Short interest1.83M
Days to cover9.2d
Short volume49.6%
Squeeze score63 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank15.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.44
Support1.13
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MGX
No recent disclosed trades by Congress in MGX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MGX · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Irish Jian See Remarks · Common Stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-10 |
Wapnick Pamela Chief Financial Officer · Common Stock · 2026-06-05 | Sell | 2.88K | $4K | 2026-06-05 | 2026-06-10 |
Irish Jian See Remarks · Common Stock · 2026-06-05 | Sell | 3.74K | $5K | 2026-06-05 | 2026-06-10 |
Irish Jian See Remarks · Common stock · 2026-06-05 | Other | — | — | 2026-06-05 | 2026-06-10 |
Wein Matthew See Remarks · Common Stock · 2026-06-05 | Sell | 558 | $725 | 2026-06-05 | 2026-06-10 |
SEC filings
EDGAR filings in MGX · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.